These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29269439)

  • 1. Tailoring the colorectal cancer disease assessment to the treatment strategy.
    Deming DA
    Gut; 2018 Jun; 67(6):996-997. PubMed ID: 29269439
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemo- and immunotherapy of colorectal cancer].
    Klein HO
    Internist (Berl); 1991 Jun; 32(6):348-53. PubMed ID: 1880013
    [No Abstract]   [Full Text] [Related]  

  • 3. Checkpoint inhibition for colorectal cancer: progress and possibilities.
    Paul B; O'Neil BH; McRee AJ
    Immunotherapy; 2016 Jun; 8(6):693-704. PubMed ID: 27197538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluating the effectiveness and timing of modification of anti-cancer drug therapies for colorectal cancer].
    Miyamoto Y; Sakamoto Y; Ozaki N; Ishimoto T; Iwatsuki M; Baba Y; Iwagami S; Yoshida N; Watanabe M; Baba H
    Gan To Kagaku Ryoho; 2012 Sep; 39(9):1326-9. PubMed ID: 22996767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy.
    Toh JWT; de Souza P; Lim SH; Singh P; Chua W; Ng W; Spring KJ
    Clin Colorectal Cancer; 2016 Dec; 15(4):285-291. PubMed ID: 27553906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolving landscape of criteria for evaluating tumor response in the era of cancer immunotherapy: From Karnofsky to iRECIST.
    Inno A; Lo Russo G; Salgarello M; Corrao G; Casolino R; Galli G; Modena A; Romano L; Pusceddu S; Greco FG; Garassino MC; Gori S
    Tumori; 2018; 104(2):88-95. PubMed ID: 29714647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiologic response assessment in metastatic colorectal cancers].
    Fabre A; Badet N; Calame P; Delabrousse E; Wespiser M; Turco C; Borg C; Jary M
    Bull Cancer; 2019 Nov; 106(11):1029-1038. PubMed ID: 31570214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Cetuximab in the Induction of Anticancer Immune Response in Colorectal Cancer Treatment.
    Holubec L; Polivka J; Safanda M; Karas M; Liska V
    Anticancer Res; 2016 Sep; 36(9):4421-6. PubMed ID: 27630277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Second-line chemotherapy for colorectal cancer].
    Komatsu Y; Sogabe S; Kawamoto Y; Iwanaga I; Uehata Y; Yuki S; Asaka M
    Gan To Kagaku Ryoho; 2009 May; 36(5):721-5. PubMed ID: 19461170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic strategies in colorectal cancer].
    Flieger D; Keller R; Fischbach W
    Dtsch Med Wochenschr; 2003 Sep; 128(37):1902-7. PubMed ID: 12970825
    [No Abstract]   [Full Text] [Related]  

  • 11. Translation from clinical trials to routine practice: how to demonstrate community benefit.
    Roder D; Buckley E
    Asia Pac J Clin Oncol; 2015 Mar; 11(1):1-3. PubMed ID: 25628060
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunotherapy in radical surgery of colorectal carcinoma].
    Brivio F; Fumagalli L; Chiarelli M; Denova M; Bertolini A; Cetta M; Nespoli A
    Chir Ital; 2007; 59(5):635-40. PubMed ID: 18019635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer mucosa antigens as a novel immunotherapeutic class of tumor-associated antigen.
    Snook AE; Eisenlohr LC; Rothstein JL; Waldman SA
    Clin Pharmacol Ther; 2007 Dec; 82(6):734-9. PubMed ID: 17898707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic therapy for colorectal cancer: focus on newer chemotherapy and novel agents.
    O'Neil BH
    Semin Radiat Oncol; 2003 Oct; 13(4):441-53. PubMed ID: 14586833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance of Carcinoembryonic Antigen Ratio and Response Evaluation Criteria in Solid Tumors as Prognostic Surrogate Indicators of Metastatic Colorectal Cancer Patients Treated with Chemotherapy.
    Huang SC; Lin JK; Lin TC; Chen WS; Yang SH; Wang HS; Lan YT; Lin CC; Jiang JK; Chang SC
    Ann Surg Oncol; 2015 Jul; 22(7):2262-8. PubMed ID: 25586242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer chemotherapy.
    Woodcock TM
    J Ky Med Assoc; 2009 Mar; 107(3):93-4. PubMed ID: 19361080
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neoadjuvant chemotherapy for colorectal cancer--time to learn a new treatment strategy?].
    Gordeev SS; Rasulov AO; Mamedli ZZ; Aliev VA; Kulushev VM
    Vopr Onkol; 2014; 60(1):18-24. PubMed ID: 24772612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Triage Trials in Colorectal Cancer.
    O'Hara MH; Hamilton SR; O'Dwyer PJ
    Cancer J; 2016; 22(3):218-22. PubMed ID: 27341602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2 and immunotherapy using monoclonal antibodies in colorectal cancer.
    Nazemalhosseini Mojarad E; Kuppen PJ
    Immunotherapy; 2013 Dec; 5(12):1267-9. PubMed ID: 24283833
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic consequences of molecular biology advances in oncology].
    Bauvet F; Awada A; Gil T; Hendlisz A
    Bull Cancer; 2009 Jan; 96(1):59-71. PubMed ID: 19211361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.